Biolase (BIOL) – Accesswire
-
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
-
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
-
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
-
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
-
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
-
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
-
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
-
BIOLASE to Present at the LD Micro 500 Virtual Conference
Back to BIOL Stock Lookup
